FEB 24, 2017 12:25 PM PST

B Cells Empower Vaccines to be Effective Long-Term

WRITTEN BY: Kara Marker

An unexpected interaction between regulatory immune cells and antibody-producing plasma cells surprised scientists, but this communication seems beneficial for the immune system’s ability to protect the body from infection.

The protozoan Toxoplasma gondii, tissue cyst in brain. Source: Science Life

From the University of Pennsylvania, researchers visualized the response of plasma cells to a parasite called Toxoplasma gondii, which causes a disease called toxoplasmosis that is especially dangerous to pregnant women and individuals with compromised immune systems. High-resolution microscopy technology provided them an inside view into live cells, where they saw plasma cells participating in some strange behavior.

Precursor B cells give rise to plasma cells, which are responsible for producing antibodies and conferring protection against infection. During exposure to T. gondii, researchers saw plasma cells from bone marrow tissue in mice disappear only to return later when the parasitic infection was under control.

“We don’t know whether these cells leave the bone marrow or die there during infection, but, either way, they are gone,” said co-leader of the study, Arielle Glatman Zaretzky. “And that set up a great system to understand what kinds of cellular interactions normally create the hospitable environment and allow the plasma cells to remain there.”

They later saw that regulatory T cells (T regs) levels declined in a similar fashion to the plasma cells in response to parasitic infection, which is when they first realized the collaborative connection between T regs and plasma cells.

This connection was thought to be that T regs were making the bone marrow “comfy” for the plasma cells, ensuring the environment was appropriately tuned for plasma cell flourishing. Without T regs, plasma cells cease to exist.

“This interaction was completely unanticipated,” said senior author Christopher A. Hunter. “If we can understand what controls these long-lived plasma cells, the maybe we can augment that interaction, making more plasma cells to, for example, enhance vaccine efficiency. Or if you want to limit autoimmunity or cancer, maybe there is an opportunity to disrupt this niche to mitigate some of these conditions.”

Both T regs and plasma cells also interact with dendritic cells, which scientists believe also promotes plasma cell survival. The present study was published in the journal Cell Reports.

Sources: Nature Reviews Immunology, Centers for Disease Control and Prevention, University of Pennsylvania

About the Author
Master's (MA/MS/Other)
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 21, 2022
Immunology
Researchers Find Cause of Flares in Rare Autoinflammatory Disease
Researchers Find Cause of Flares in Rare Autoinflammatory Disease
Mevalonate kinase deficiency (MKD) is a rare genetic disease caused by mutations in the mevalonate kinase gene, which en ...
NOV 04, 2022
Coronavirus
GABA Has Potential as an Inexpensive COVID-19 Treatment
GABA Has Potential as an Inexpensive COVID-19 Treatment
It may be possible to reduce the severity of COVID-19 symptoms with an inexpensive amino acid that could open up new tre ...
DEC 19, 2022
Clinical & Molecular DX
Researchers Use Single-Cell Sequencing to Unravel the Origins of a Rare Cancer-Like Disorder that Affects Children
Researchers Use Single-Cell Sequencing to Unravel the Origins of a Rare Cancer-Like Disorder that Affects Children
Langerhans cell histiocytosis (LCH), a rare disorder that primarily affects the immune system, mainly affects children a ...
DEC 26, 2022
Immunology
An Antibody Successfully Treats Over 70% of Multiple Myeloma Patients in Trial
An Antibody Successfully Treats Over 70% of Multiple Myeloma Patients in Trial
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h ...
JAN 04, 2023
Health & Medicine
Jack-of-All-Trades Psychiatric Treatment Had Unknown Anti-Inflammatory Actions
Jack-of-All-Trades Psychiatric Treatment Had Unknown Anti-Inflammatory Actions
The new anti-psychotic lumateperone was developed to treat schizophrenia and bipolar I and II disorder in adults. But wh ...
JAN 16, 2023
Cell & Molecular Biology
The First Cross-Species Signaling Pathway is Discovered
The First Cross-Species Signaling Pathway is Discovered
For the first time, a signaling pathway that links two species has been revealed - molecules generated when bacteria inf ...
Loading Comments...